Detalhe da pesquisa
1.
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Pharm Res
; 40(11): 2653-2666, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38082089
2.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol
; 39(2): 187-196, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083774
3.
Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis.
J Am Acad Dermatol
; 74(2): 280-7.e1-3, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26775775
4.
Etanercept treatment for children and adolescents with plaque psoriasis.
N Engl J Med
; 358(3): 241-51, 2008 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18199863
5.
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial.
Am J Clin Dermatol
; 22(2): 243-255, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33655423
6.
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
Am J Clin Dermatol
; 22(1): 101-115, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33481203
7.
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
Am J Clin Dermatol
; 21(1): 119-131, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31823222
8.
Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.
JAMA Dermatol
; 156(1): 44-56, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31693077